Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationHematopoietic Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsBone and BonesTransplantation ConditioningLeukemiaAnemia, AplasticTransplantation ChimeraCyclophosphamideLiver TransplantationTissue DonorsGraft SurvivalBusulfanHematopoiesisCombined Modality TherapyBone Marrow PurgingHistocompatibility TestingHistocompatibilityTreatment OutcomeBone Marrow DiseasesTransplantation, IsogeneicRecurrenceLeukemia, Myeloid, AcuteMice, Inbred C57BLHematologic NeoplasmsKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisLeukemia, MyeloidImmunosuppressive AgentsBone Marrow ExaminationLymphoma, Non-HodgkinRemission InductionGraft RejectionColony-Forming Units AssayHepatic Veno-Occlusive DiseaseChemotherapy, AdjuvantBone Marrow NeoplasmsBone RemodelingAcute DiseaseTransplantation ImmunologyStem Cell TransplantationDisease-Free SurvivalSurvival RateImmunosuppressionGraft vs Host ReactionLymphocyte DepletionT-LymphocytesMyelodysplastic SyndromesLeukocyte TransfusionEtoposideCell DifferentiationChimeraHeart TransplantationSevere Combined ImmunodeficiencyHematologic DiseasesHLA AntigensAntigens, CD34CarmustineFollow-Up StudiesCytarabineActuarial AnalysisRetrospective StudiesGranulocyte Colony-Stimulating FactorPrognosisAntineoplastic AgentsCyclosporineLymphocyte TransfusionFlow CytometryLung TransplantationMelphalanGraft vs Tumor EffectBone DensityLymphomaCells, CulturedLeukocyte CountPancytopeniaMethotrexateGraft vs Leukemia EffectSpleenMice, Inbred BALB CHodgkin DiseaseNuclear FamilyMultiple MyelomaOrgan TransplantationCytomegalovirus InfectionsGranulocytesBlood CellsHematopoietic SystemMice, Knockout